Sort by

Send to:

Choose Destination

Selected items

Items: 4


Leveraging APOBEC3 proteins to alter the HIV mutation rate and combat AIDS.

Hultquist JF, Harris RS.

Future Virol. 2009 Nov 1;4(6):605.


Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics.

Albin JS, Harris RS.

Expert Rev Mol Med. 2010 Jan 22;12:e4. doi: 10.1017/S1462399409001343. Review.


APOBEC3G inhibits elongation of HIV-1 reverse transcripts.

Bishop KN, Verma M, Kim EY, Wolinsky SM, Malim MH.

PLoS Pathog. 2008 Dec;4(12):e1000231. doi: 10.1371/journal.ppat.1000231. Epub 2008 Dec 5.


Exosomes packaging APOBEC3G confer human immunodeficiency virus resistance to recipient cells.

Khatua AK, Taylor HE, Hildreth JE, Popik W.

J Virol. 2009 Jan;83(2):512-21. doi: 10.1128/JVI.01658-08. Epub 2008 Nov 5.

Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk